First time in USA, A Gene therapy to treat cancer by using patients own blood cell has been approved. Chimeric antigen receptors T cell therapy was approved by the Food and Drug Administration on Wednesday, making it the first gene therapy to be available in the U.S. It was approved for young people up to age 25 with a form of acute lymphoblastic leukemia (ALL).
The list price is $475,000 for one-time treatment. There is a lot of criticism regarding such high price of this drug but as Cancer drugs are evolved after much research spending hugh money so, the company demanded that if such price is not provided in future no company will invest in such cancer research.Therefore, The company planned that to price the therapy, “based on the clinical outcomes achieved,” and specifically only allow for payment when ALL patients “respond to therapy by the end of the first month.” The company…
